HTG Molecular Diagnostics Inc (HTGMQ)

[INFINITI]

HTG Molecular Diagnostics (NASDAQ:HTGM) stock is rocketing higher on Monday as investors prepare for a major event on Dec. 13.

That’s when the company will hold its HTG Therapeutics key opinion leader webinar. The title of this presentation is The Role of RNA Profiling in Drug Discovery and Analysis. It will start at 11:00 a.m. Eastern Time with Dr. Robert Spitale leading it.

To go along with that, HTG Molecular Diagnostics intends to share information from its transcriptome-informed drug discovery process. It will show how RNA profiling can help in understanding post-target engagement consequences.

What’s Happening With HTGM Stock Today

Ahead of this presentation, shares of HTGM stock are seeing extra trading activity. As of this writing, more than 82 million shares of the stock have changed hands. That’s a massive boost compared to the company’s daily average trading volume of about 830,000 shares.